Demethylating therapy increases cytotoxicity of CD44v6 CAR-T cells against acute myeloid leukemia.

Frontiers in immunology(2023)

Cited 1|Views8
No score
Abstract
Dec or Aza in combination with CD44v6 CAR-T cells is a promising combination therapy for AML patients.
More
Translated text
Key words
acute myeloid leukemia,cytotoxicity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined